Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-391-8 | CAS number: 7529-22-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 30 to May 14, 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- Skin was abraded before exposure to the test substance.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- 4-methylmorpholine 4-oxide, monohydrate
- EC Number:
- 231-391-8
- EC Name:
- 4-methylmorpholine 4-oxide, monohydrate
- Cas Number:
- 7529-22-8
- Molecular formula:
- C5H11NO2
- IUPAC Name:
- 4-methyl-4λ⁵-morpholin-4-one
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): 4236-40-5
- Substance type: Yellow liquid
- Storage condition of test material: Room temperature
- Purity: 50% aqueous solution
- Other: Specific gravity: 1.136
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dutchland Laboratories, Inc., Denver, Pennsylvania
- Age at study initiation: Young adults
- Weight at study initiation: males: 2.8 to 2.9 kilograms; females: 3.4 to 3.9 kilograms
- Housing: Suspended stainless steel, animals individually housed
- Diet (e.g. ad libitum): Purina Rabbit Chow, ad libitum
- Water (e.g. ad libitum): Automatic watering system, ad libitum Municipal water supply (Elizabethtown Water Co.)
- Acclimation period: 38 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17,8°C - 20,6 °C (64-69°F)
- Humidity (%): monitored daily, no more details specified
- Photoperiod (hrs dark / hrs light): 12 hours light, 12 hours dark
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: trunk (dorsal and ventral surface and sides from scapular to pelvic area)
- % coverage: at least 20% of the body surface area
- Type of wrap if used: The substance was applied directly onto the exposed skin of the animal, and spread evenly over the entire area. A layer of 8-ply gauze was then wrapped around the animal to cover the application site. The animal was then wrapped in an impervious plastic sleeve, designed to contain the test material without leakage or undue pressure. The sleeve was secured with masking tape and Elizabethan collars were placed on all animals.
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Following approximately 24 hours of exposure, wrappings were removed and the test site wipped free of excess test material. After 30 minutes, dermal observations were made.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 8000 mg/kg at a dose volume of 7.0 mL/kg - Duration of exposure:
- 24 hours
- Doses:
- 8000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:
viability check: twice daily
observations of pharmacologic and toxicologic signs: approximately 1, 2, and 4 hours after dosing and daily thereafter for fourteen days
body weights: pre-dose, at the time of clipping (weights used for calculation of doses), days 7 and 14
skin irritation: approx. 30 min after removal of the occlusive wrapping and scored after Draize
- Necropsy of survivors performed: yes: all animals surviving at termination of the observation period (day 14) were killed by an intravenous overdose of sodium pentabarbital and examined grossly. All abnormalities were recorded but no tissues were saved
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 8 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- All of the animals survived the fourteen-day post-dose period.
- Clinical signs:
- other: Soft stool, fecal staining and staining of the ano-genital area were noted sporadically in single animals on Days 1 and 2. Several animals exhibited nasal discharge between Days 4 and 14.
- Gross pathology:
- Observations made at necropsy were similar to those seen in control animals in the laboratory or were considered to represent normal physiologic variations.
- Other findings:
- Irritation: after 24h animals exhibited well-defined or moderate to severe erythema, generally with very slight or slight edema.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- All animals survived the fourteen-day post-dose period. The LD50 value of the substance is greater than 8000 mg/kg. As a 50% aqueous solution is used, the LD50 for the pure NMMO is considered to be greater than 4000 mg/kg.
Based on the results of this study and according to the criteria of the CLP Regulation, the substance should not be classified for acute dermal toxicity. - Executive summary:
In an acute dermal toxicity study performed equivalent or similar to OECD TG 402, groups of 5 New Zealand White rabbits/sex were dermally exposed to 4-methylmorpholine 4-oxide (50% aqueous solution) for 24 hours toat least 20% of the body surface area at a dose of 8000 mg/kg bw. Animals were then observed for 14 days.
There were no mortalities observed. All animals exhibited weight losses or showed no change in weight at Day 7, but all (except one female) gained weight between Days 7 and 14. However, two of the males exhibited overall weight loss at Day 14. Observations made at necropsy were similar to those seen in control animals in the laboratory or were considered to represent normal physiologic variations. After 24h, animals exhibited well-defined or moderate to severe erythema, generally with very slight or slight edema.
Based on these findings, the dermal LD50 for males and females was considered to be > 8000 mg/kg bw.
As a 50% aqueous solution is used, the LD50 for the pure NMMO is considered to be greater than 4000 mg/kg. Based on the results of this study and according to the criteria of the CLP Regulation, the substance should not be classified for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
